Calciscon
Description: Calciscon's T50® test predicts cardiovascular disease risk via calcification analysis, guiding effective treatment to prevent up to 50% of events.
Country: Switzerland
Based in: Biel / Bienne
Founded: 2013
Funding Stage: Series A/B
Tags: ['Calcification', 'cardiovascular', 'kidney', 'IVD']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.